Serotonin Changes in Cancer Patients During Chemotherapy
Author Information
Author(s): L.X. Cubeddu, I.S. Hoffmann, N.T. Fuenmayor, J.J. Malave
Primary Institution: Central University of Venezuela, School of Pharmacy and Perez Carreno Hospital
Hypothesis
Does the metabolism of serotonin in cancer patients relate to nausea and vomiting induced by chemotherapeutic drugs?
Conclusion
Chemotherapy drugs, especially high-dose cisplatinum and dacarbazine, significantly increase serotonin metabolism, which correlates with the severity of nausea and vomiting.
Supporting Evidence
- High-dose cisplatinum significantly increased urinary excretion of 5-HIAA.
- Dacarbazine also induced marked increases in serotonin metabolism.
- Patients receiving high-dose cisplatinum experienced intense nausea and vomiting.
- Low-dose cisplatinum and cyclophosphamide produced smaller increases in serotonin metabolism.
- Octreotide did not inhibit the increase in serotonin metabolism or nausea.
Takeaway
When cancer patients take certain chemotherapy drugs, their bodies release more serotonin, which can make them feel sick and vomit.
Methodology
The study involved 54 chemotherapy-naive cancer patients, measuring serotonin and its metabolite 5-HIAA in blood and urine before and after chemotherapy.
Potential Biases
Potential bias from excluding patients with prior treatments or those experiencing nausea and vomiting.
Limitations
The study excluded patients with prior chemotherapy or those with abnormal liver or renal function, which may limit generalizability.
Participant Demographics
54 patients, aged 18 and older, with histologically confirmed cancer.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website